Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Tauopathy: A common mechanism for neurodegeneration and brain aging
Pampa Saha, Nilkantha Sen
Mechanisms of Ageing and Development (2019) Vol. 178, pp. 72-79
Open Access | Times Cited: 112

Showing 1-25 of 112 citing articles:

The Microbiota–Gut–Brain Axis and Alzheimer’s Disease: Neuroinflammation Is to Blame?
Ashwinipriyadarshini Megur, Daiva Baltriukienė, Virginija Bukelskienė, et al.
Nutrients (2020) Vol. 13, Iss. 1, pp. 37-37
Open Access | Times Cited: 227
Type 2 Diabetes Mellitus and Alzheimer’s Disease: Shared Molecular Mechanisms and Potential Common Therapeutic Targets
Rim Hamzé, Etienne Delangre, Stefania Tolu, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 23, pp. 15287-15287
Open Access | Times Cited: 91
Transgenic Mouse Models of Alzheimer’s Disease: An Integrative Analysis
Raquel Sánchez‐Varo, Marina Mejias‐Ortega, Juan José Fernandez-Valenzuela, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 10, pp. 5404-5404
Open Access | Times Cited: 80
High-frequency terahertz waves disrupt Alzheimer’s β-amyloid fibril formation
Wenyu Peng, Zhi Zhu, Jing Lou, et al.
eLight (2023) Vol. 3, Iss. 1
Open Access | Times Cited: 60
CSF and Blood Biomarkers in Neuroinflammatory and Neurodegenerative Diseases: Implications for Treatment
Lorenzo Gaetani, Federico Paolini Paoletti, G. Bellomo, et al.
Trends in Pharmacological Sciences (2020) Vol. 41, Iss. 12, pp. 1023-1037
Closed Access | Times Cited: 72
Prion-like C-Terminal Domain of TDP-43 and α-Synuclein Interact Synergistically to Generate Neurotoxic Hybrid Fibrils
Shailendra Dhakal, Courtney E. Wyant, Hannah E. George, et al.
Journal of Molecular Biology (2021) Vol. 433, Iss. 10, pp. 166953-166953
Open Access | Times Cited: 57
Circadian rhythms in the blood–brain barrier: impact on neurological disorders and stress responses
Nicolette Schurhoff, Michał Toborek
Molecular Brain (2023) Vol. 16, Iss. 1
Open Access | Times Cited: 40
Gut instincts: Unveiling the connection between gut microbiota and Alzheimer's disease
Vasu Peddinti, Manoj Mohan Avaghade, Sunil Suthar, et al.
Clinical Nutrition ESPEN (2024) Vol. 60, pp. 266-280
Closed Access | Times Cited: 8
The Bewildering Effect of AMPK Activators in Alzheimer’s Disease: Review of the Current Evidence
Brhane Teklebrhan Assefa, Gebrehiwot Gebremedhin Tafere, Dawit Zewdu Wondafrash, et al.
BioMed Research International (2020) Vol. 2020, pp. 1-18
Open Access | Times Cited: 54
Novel Variance-Component TWAS method for studying complex human diseases with applications to Alzheimer’s dementia
Shizhen Tang, Aron S. Buchman, Philip L. De Jager, et al.
PLoS Genetics (2021) Vol. 17, Iss. 4, pp. e1009482-e1009482
Open Access | Times Cited: 51
Repetitive mild traumatic brain injury in mice triggers a slowly developing cascade of long-term and persistent behavioral deficits and pathological changes
Xiaoyun Xu, Matthew F Cowan, Flávio H. Beraldo, et al.
Acta Neuropathologica Communications (2021) Vol. 9, Iss. 1
Open Access | Times Cited: 48
Dendrimers in Alzheimer’s Disease: Recent Approaches in Multi-Targeting Strategies
Cécile Arbez‐Gindre, Barry R. Steele, Maria Micha‐Screttas
Pharmaceutics (2023) Vol. 15, Iss. 3, pp. 898-898
Open Access | Times Cited: 19
Tau Protein Alterations Induced by Hypobaric Hypoxia Exposure
Eduardo Pena, Rocio San Martin-Salamanca, Samia El Alam, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 2, pp. 889-889
Open Access | Times Cited: 7
Nanoligomers targeting NF-κB and NLRP3 reduce neuroinflammation and improve cognitive function with aging and tauopathy
Devin Wahl, Sydney Risen, Shelby C. Osburn, et al.
Journal of Neuroinflammation (2024) Vol. 21, Iss. 1
Open Access | Times Cited: 7
Neuronal ageing is promoted by the decay of the microtubule cytoskeleton
Pilar Okenve-Ramos, Rory Gosling, Monika Chojnowska-Monga, et al.
PLoS Biology (2024) Vol. 22, Iss. 3, pp. e3002504-e3002504
Open Access | Times Cited: 6
Cofilin, a Master Node Regulating Cytoskeletal Pathogenesis in Alzheimer’s Disease
David E. Kang, Jung A. Woo
Journal of Alzheimer s Disease (2019) Vol. 72, Iss. s1, pp. S131-S144
Open Access | Times Cited: 48
Sulfhydration of AKT triggers Tau-phosphorylation by activating glycogen synthase kinase 3β in Alzheimer’s disease
Tanusree Sen, Pampa Saha, Tong Jiang, et al.
Proceedings of the National Academy of Sciences (2020) Vol. 117, Iss. 8, pp. 4418-4427
Open Access | Times Cited: 48
Untangling senescent and damage‐associated microglia in the aging and diseased brain
Pei Ying Ng, Taylor McNeely, Darren J. Baker
FEBS Journal (2021) Vol. 290, Iss. 5, pp. 1326-1339
Open Access | Times Cited: 39
Neurodegeneration Induced by Anti-IgLON5 Antibodies Studied in Induced Pluripotent Stem Cell-Derived Human Neurons
Matias Ryding, Mattias Gamre, Mette Scheller Nissen, et al.
Cells (2021) Vol. 10, Iss. 4, pp. 837-837
Open Access | Times Cited: 37
PET imaging of neural activity, β-amyloid, and tau in normal brain aging
Kai Zhang, Hiroshi Mizuma, Xiaohui Zhang, et al.
European Journal of Nuclear Medicine and Molecular Imaging (2021) Vol. 48, Iss. 12, pp. 3859-3871
Closed Access | Times Cited: 36
Fused Cycloheptatriene–BODIPY Is a High-Performance Near-Infrared Probe to Image Tau Tangles
Tianxin Xie, Yuying Li, Chuan Tian, et al.
Journal of Medicinal Chemistry (2022) Vol. 65, Iss. 21, pp. 14527-14538
Closed Access | Times Cited: 23
Role of Tau in Various Tauopathies, Treatment Approaches, and Emerging Role of Nanotechnology in Neurodegenerative Disorders
Preetpal Kaur, Alisha Khera, Hema Kumari Alajangi, et al.
Molecular Neurobiology (2022) Vol. 60, Iss. 3, pp. 1690-1720
Closed Access | Times Cited: 23
Chronic kidney disease causes blood-brain barrier breakdown via urea-activated matrix metalloproteinase-2 and insolubility of tau protein
Hisazumi Matsuki, Shintaro Mandai, Hiroki Shiwaku, et al.
Aging (2023)
Open Access | Times Cited: 15
Impact of GSK-3β and CK-1δ on Wnt signaling pathway in alzheimer disease: A dual target approach
Vinita Sharma, Prabodh Chander Sharma, Jurnal Reang, et al.
Bioorganic Chemistry (2024) Vol. 147, pp. 107378-107378
Closed Access | Times Cited: 5
Exploring the effect of gut microbiome on Alzheimer's disease
Ramtin Pourahmad, Kiarash Saleki, Mehrad Zare Gholinejad, et al.
Biochemistry and Biophysics Reports (2024) Vol. 39, pp. 101776-101776
Open Access | Times Cited: 5
Page 1 - Next Page

Scroll to top